Koninklijke Philips (PHG) FCF Payout Ratio Growth (1y) (2010 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.00% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -67.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.45% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -51.96% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 9,472.45% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 2.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34,992.05% |
| Dec 31, 2024 | 53.41% |
| Dec 31, 2023 | 99.92% |
| Jun 30, 2023 | -100.12% |
| Dec 31, 2022 | -252.32% |
| Jun 30, 2022 | 436.09% |
| Dec 31, 2021 | -77,313.43% |
| Sep 30, 2021 | -15,591.03% |
| Dec 31, 2020 | 99.81% |
| Sep 30, 2020 | 99.07% |
| Dec 31, 2019 | -85.24% |
| Jun 30, 2019 | 47.72% |
| Dec 31, 2018 | -163.12% |
| Dec 31, 2017 | 19,975.53% |
| Dec 31, 2016 | 100.70% |
| Sep 30, 2016 | 94.18% |
| Jun 30, 2016 | 98.28% |
| Dec 31, 2015 | -5.14% |
| Jun 30, 2013 | -49.95% |
| Dec 31, 2012 | 33.88% |
| Sep 30, 2012 | 91.79% |
| Jun 30, 2012 | -113.17% |
| Dec 31, 2011 | -7,117.88% |
| Sep 30, 2011 | -137.60% |
| Jun 30, 2011 | 933.65% |
| Dec 31, 2010 | 99.59% |